{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:03:57Z","timestamp":1792796637449,"version":"4.5.0"},"reference-count":65,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Epsilon Xi Chapter of Sigma Theta Tau Research"},{"name":"National Cancer Institute NCORP","award":["UG1 CA189961"],"award-info":[{"award-number":["UG1 CA189961"]}]},{"name":"National Cancer Institute NCORP","award":["R01CA177592"],"award-info":[{"award-number":["R01CA177592"]}]},{"name":"National Cancer Institute NCORP","award":["U01CA233167"],"award-info":[{"award-number":["U01CA233167"]}]},{"name":"National Cancer Institute NCORP","award":["K24 AG056589"],"award-info":[{"award-number":["K24 AG056589"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Symptom trajectories vary among patients during cancer treatment. The National Institutes of Health resilience model, which defines resilience as the ability to resist, recover, or grow from stressors, may be useful in understanding these variations. This study examined variations in symptom trajectories through the lens of resilience among older adults with advanced cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This longitudinal quantitative study included patients aged 70 and older with advanced cancer who were receiving treatment regimens associated with a high risk of treatment-related toxicities, using data from the GAP70+ study (NCT02054741). A summary severity score of 24 symptoms from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events and functional status (measured by instrumental activities of daily living) were assessed prior to the treatment regimen initiation, at 4-6\u2009weeks, 3\u2009months, and 6\u2009months later. Symptom trajectories were estimated using growth mixture models. Resilience was indicated by trajectories of resisting, recovering, or growing (ie, improving from moderate\/severe to none\/mild severity). Its association with functional status was examined using longitudinal linear mixed models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study included 710 patients (average age 77.2, 43.2% female, 88.0% receiving chemotherapy). Overall, 17.7% of patients showed resilience in symptom response, which was associated with higher baseline functional status (13.2 vs 12.0, P\u202f&amp;lt;.001) and stable functioning over 6 months. In contrast, non-resilience in symptom response was associated with a functional decline of 0.7-0.9 points without recovery by 6 months (P&amp;lt;.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Resilience in symptom response provides a novel perspective on symptom trajectory variations. Future research should explore underlying contributing factors to inform interventions that promote resilient symptom responses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/oncolo\/oyag094","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:48:50Z","timestamp":1773838130000},"source":"Crossref","is-referenced-by-count":3,"title":["Resilience in symptom response to cancer treatment: a new lens for examining variable symptom trajectories in older adults with advanced cancer"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9948-8936","authenticated-orcid":false,"given":"Zhihong","family":"Zhang","sequence":"first","affiliation":[{"name":"University of Rochester, School of Nursing , Rochester, NY, 14642,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Culakova","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, Department of Surgery , Rochester, NY, 14642,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6978-0418","authenticated-orcid":false,"given":"Kah Poh","family":"Loh","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, Division of Hematology\/Oncology, Department of Medicine and Wilmot Cancer Institute , Rochester, NY, 14642,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1095-1873","authenticated-orcid":false,"given":"Kathi L","family":"Heffner","sequence":"additional","affiliation":[{"name":"University of Rochester, School of Nursing , Rochester, NY, 14642,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Mohamed","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, Division of Hematology\/Oncology, Department of Medicine and Wilmot Cancer Institute , Rochester, NY, 14642,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael G","family":"Tylock","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, Division of Hematology\/Oncology, Department of Medicine and Wilmot Cancer Institute , Rochester, NY, 14642,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Wells","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, Division of Hematology\/Oncology, Department of Medicine and Wilmot Cancer Institute , Rochester, NY, 14642,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona A","family":"Stauffer","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, Division of Hematology\/Oncology, Department of Medicine and Wilmot Cancer Institute , Rochester, NY, 14642,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0867-327X","authenticated-orcid":false,"given":"Supriya","family":"Mohile","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, Division of Hematology\/Oncology, Department of Medicine and Wilmot Cancer Institute , Rochester, NY, 14642,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Flannery","sequence":"additional","affiliation":[{"name":"University of Rochester, School of Nursing , Rochester, NY, 14642,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"2026060406350092000_oyag094-B1","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s11912-024-01567-w","article-title":"Epidemiology of cancer in older adults: a systematic review","volume":"26","author":"Pilleron","year":"2024","journal-title":"Curr Oncol Rep"},{"key":"2026060406350092000_oyag094-B2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12877-024-04788-7","article-title":"Physical symptoms and anxiety and depression in older patients with advanced cancer in China: a network analysis","volume":"24","author":"Tang","year":"2024","journal-title":"BMC Geriatr"},{"key":"2026060406350092000_oyag094-B3","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s00520-019-05003-9","article-title":"The usefulness and prognostic value of memorial symptom Assessment-Short form and condensed memorial symptom assessment scale in assessment of lung cancer patients","volume":"28","author":"Bircan","year":"2020","journal-title":"Supportive Care Cancer"},{"key":"2026060406350092000_oyag094-B4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cllc.2017.02.008","article-title":"Emotional problems, quality of life, and symptom burden in patients with lung cancer","volume":"18","author":"Morrison","year":"2017","journal-title":"Clin Lung Cancer"},{"key":"2026060406350092000_oyag094-B5","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1177\/0269216319825972","article-title":"Frailty identified by geriatric assessment is associated with poor functioning, high symptom burden and increased risk of physical decline in older cancer patients: prospective observational study","volume":"33","author":"Kirkhus","year":"2019","journal-title":"Palliat Med"},{"key":"2026060406350092000_oyag094-B6","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1634\/theoncologist.2019-0581","article-title":"A randomized trial of Real-Time geriatric assessment reporting in nonelectively hospitalized older adults with cancer","volume":"25","author":"Jolly","year":"2020","journal-title":"Oncologist"},{"key":"2026060406350092000_oyag094-B7","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1002\/cncr.30575","article-title":"Symptom incidence, distress, cancer-related distress, and adherence to chemotherapy among african American women with breast cancer","volume":"123","author":"Yee","year":"2017","journal-title":"Cancer"},{"key":"2026060406350092000_oyag094-B8","doi-asserted-by":"publisher","first-page":"104434","DOI":"10.1016\/j.oraloncology.2019.09.026","article-title":"Symptom burden among head and neck cancer patients in the first year after diagnosis: association with primary treatment modality","volume":"99","author":"Allen-Ayodabo","year":"2019","journal-title":"Oral Oncol"},{"key":"2026060406350092000_oyag094-B9","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1007\/s00520-018-4598-y","article-title":"Symptoms during chemotherapy in colorectal cancer patients","volume":"27","author":"R\u00f6hrl","year":"2019","journal-title":"Supportive Care Cancer"},{"key":"2026060406350092000_oyag094-B10","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s00066-017-1146-5","article-title":"Patient-reported symptoms during radiotherapy: clinically relevant symptom burden in patients treated with palliative and curative intent","volume":"193","author":"K\u00f6rner","year":"2017","journal-title":"Strahlenther Onkol"},{"key":"2026060406350092000_oyag094-B11","doi-asserted-by":"publisher","first-page":"n1647","DOI":"10.1136\/bmj.n1647","article-title":"Real time remote symptom monitoring during chemotherapy for cancer: European Multicentre Randomised Controlled Trial (eSMART)","volume":"374","author":"Maguire","year":"2021","journal-title":"BMJ"},{"key":"2026060406350092000_oyag094-B12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.athoracsur.2019.08.030","article-title":"Patient-Reported symptoms for esophageal cancer patients undergoing curative intent treatment","volume":"109","author":"Gupta","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"2026060406350092000_oyag094-B13","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1097\/IGC.0000000000001287","article-title":"Symptom experience and self-rated physical functioning in patients with ovarian cancer receiving chemotherapy: a longitudinal study","volume":"28","author":"Vistad","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"2026060406350092000_oyag094-B14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jpainsymman.2021.06.019","article-title":"Determinants of distinct trajectories of fatigue in patients undergoing chemotherapy for a metastatic colorectal cancer: 6-Month follow-up using growth mixture modeling","volume":"63","author":"Baussard","year":"2022","journal-title":"J Pain Symptom Manage"},{"key":"2026060406350092000_oyag094-B15","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1080\/0284186X.2021.1981550","article-title":"Symptom trajectories in breast cancer survivors: growth mixture analysis of patient-reported pain, fatigue, insomnia, breast and arm symptoms","volume":"60","author":"Nielsen","year":"2021","journal-title":"Acta Oncol"},{"key":"2026060406350092000_oyag094-B16","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1080\/15402002.2020.1869005","article-title":"Insomnia and fatigue symptom trajectories in breast cancer: a longitudinal cohort study","volume":"19","author":"Bean","year":"2021","journal-title":"Behav Sleep Med"},{"key":"2026060406350092000_oyag094-B17","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/cncr.33327","article-title":"Do all patients with cancer experience fatigue? A longitudinal study of fatigue trajectories in women with breast cancer","volume":"127","author":"Bower","year":"2021","journal-title":"Cancer"},{"key":"2026060406350092000_oyag094-B18"},{"key":"2026060406350092000_oyag094-B19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/smi.3260","article-title":"Conceptualizing a resilience research framework at the national institutes of health","volume":"39","author":"Brown","year":"2023","journal-title":"Stress Health"},{"key":"2026060406350092000_oyag094-B20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jgo.2021.07.007","article-title":"Impact of radiotherapy on daily function among older adults living with advanced cancer (RT impact on function in advanced cancer)","volume":"13","author":"Nehlsen","year":"2022","journal-title":"J Geriatr Oncol"},{"key":"2026060406350092000_oyag094-B21","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1007\/s00520-021-06752-2","article-title":"Functional status in older patients with lung cancer: an observational cohort study","volume":"30","author":"Couderc","year":"2022","journal-title":"Supportive Care Cancer"},{"key":"2026060406350092000_oyag094-B22","doi-asserted-by":"publisher","first-page":"517","DOI":"10.11124\/JBISRIR-2016003282","article-title":"The short-term impact of colorectal cancer treatment on physical activity, functional status and quality of life: a systematic review","volume":"15","author":"Cabilan","year":"2017","journal-title":"JBI Database System Rev Implement Rep"},{"key":"2026060406350092000_oyag094-B23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jgo.2017.01.003","article-title":"Functional status decline in older patients with breast and colorectal cancer after cancer treatment: a prospective cohort study","volume":"8","author":"van Abbema","year":"2017","journal-title":"J Geriatr Oncol"},{"key":"2026060406350092000_oyag094-B24","doi-asserted-by":"publisher","first-page":"101366","DOI":"10.1016\/j.jgo.2022.08.015","article-title":"Change in four measures of physical function among older adults during lung cancer treatment: a mixed methods cohort study","volume":"14","author":"Singhal","year":"2023","journal-title":"J Geriatr Oncol"},{"key":"2026060406350092000_oyag094-B25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/ANS.0000000000000446","article-title":"An analysis and evaluation of Kumpfer\u2019s resilience framework","volume":"46","author":"Zhang","year":"2023","journal-title":"Adv Nurs Sci"},{"key":"2026060406350092000_oyag094-B26","first-page":"179","author":"Kumpfer","year":"2022"},{"key":"2026060406350092000_oyag094-B27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5152\/ArcHealthSciRes.2023.0137","article-title":"The relationship of functional status with self-efficacy and resilience in stroke patients","volume":"10","author":"Takil","year":"2023","journal-title":"Arch Health Sci Res"},{"key":"2026060406350092000_oyag094-B28","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.apmr.2015.02.023","article-title":"Resilience predicts functional outcomes in people aging with disability: a longitudinal investigation","volume":"96","author":"Silverman","year":"2015","journal-title":"Arch Phys Med Rehabil"},{"key":"2026060406350092000_oyag094-B29","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/S0140-6736(21)01789-X","article-title":"Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study","volume":"398","author":"Mohile","year":"2021","journal-title":"Lancet"},{"key":"2026060406350092000_oyag094-B30","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1017\/S0954579400004156","article-title":"The construct of resilience: implications for interventions and social policies","volume":"12","author":"Luthar","year":"2000","journal-title":"Dev Psychopathol"},{"key":"2026060406350092000_oyag094-B31","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1037\/0003-066X.56.3.227","article-title":"Ordinary magic: resilience processes in development","volume":"56","author":"Masten","year":"2001","journal-title":"Am Psychol"},{"key":"2026060406350092000_oyag094-B32","doi-asserted-by":"publisher","first-page":"e234198","DOI":"10.1001\/jamanetworkopen.2023.4198","article-title":"An unsupervised machine learning approach to evaluating the association of symptom clusters with adverse outcomes among older adults with advanced cancer: a secondary analysis of a randomized clinical trial","volume":"6","author":"Xu","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026060406350092000_oyag094-B33","author":"Fillenbaum","year":"1988"},{"key":"2026060406350092000_oyag094-B34","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/geronj\/36.4.428","article-title":"The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire","volume":"36","author":"Fillenbaum","year":"1981","journal-title":"J Gerontol"},{"key":"2026060406350092000_oyag094-B35","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/jpepsy\/jst085","article-title":"An introduction to latent variable mixture modeling (part 2): longitudinal latent class growth analysis and growth mixture models","volume":"39","author":"Berlin","year":"2014","journal-title":"J Pediatr Psychol"},{"key":"2026060406350092000_oyag094-B36","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/j.1530-0277.2000.tb02070.x","article-title":"Integrating person-centered and variable-centered analyses: growth mixture modeling with latent trajectory classes","volume":"24","author":"Muth\u00e9n","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"2026060406350092000_oyag094-B37","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1751-9004.2007.00054.x","article-title":"An introduction to latent class growth analysis and growth mixture modeling","volume":"2","author":"Jung","year":"2008","journal-title":"Social Personal Psych"},{"key":"2026060406350092000_oyag094-B38","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1200\/JCO.21.00195","article-title":"Understanding treatment tolerability in older adults with cancer","volume":"39","author":"Flannery","year":"2021","journal-title":"J Clin Oncol"},{"key":"2026060406350092000_oyag094-B39","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1080\/0284186X.2021.1917776","article-title":"Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin\u2019s lymphoma; symptom burden and quality of life","volume":"60","author":"Eikeland","year":"2021","journal-title":"Acta Oncol"},{"key":"2026060406350092000_oyag094-B40","doi-asserted-by":"publisher","first-page":"821","DOI":"10.6004\/jnccn.2021.7026","article-title":"Chemotherapy-induced peripheral neurotoxicity in cancer survivors: predictors of long-term patient outcomes","volume":"19","author":"Battaglini","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"2026060406350092000_oyag094-B41","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1007\/s00520-020-05946-4","article-title":"Distinct profiles of multiple co-occurring symptoms in patients with gastrointestinal cancers receiving chemotherapy","volume":"29","author":"Lin","year":"2021","journal-title":"Support Care Cancer"},{"key":"2026060406350092000_oyag094-B42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1188\/20.ONF.187-202","article-title":"Common and co-occurring symptoms experienced by patients with gastric cancer","volume":"47","author":"Lin","year":"2020","journal-title":"Oncol Nurs Forum"},{"key":"2026060406350092000_oyag094-B43","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1200\/JCO.2016.70.1474","article-title":"Integration of palliative care into standard oncology care: American Society of Clinical Oncology Clinical Practice guideline update","volume":"35","author":"Ferrell","year":"2017","journal-title":"J Clin Oncol"},{"key":"2026060406350092000_oyag094-B44","doi-asserted-by":"publisher","first-page":"780","DOI":"10.6004\/jnccn.2021.0033","article-title":"NCCN guidelines\u00ae insights: Palliative care, version 2.2021: featured updates to the NCCN guidelines","volume":"19","author":"Dans","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"key":"2026060406350092000_oyag094-B45","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1200\/cci.20.00081","article-title":"Clinical utility and user perceptions of a digital system for electronic patient-reported symptom monitoring during routine cancer care: findings from the PRO-TECT trial","volume":"4","author":"Basch","year":"2020","journal-title":"JCO Clin Cancer Inform"},{"key":"2026060406350092000_oyag094-B46","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1001\/jama.2022.9265","article-title":"Effect of electronic symptom monitoring on Patient-Reported outcomes among patients with metastatic cancer: a randomized clinical trial","volume":"327","author":"Basch","year":"2022","journal-title":"JAMA"},{"key":"2026060406350092000_oyag094-B47","doi-asserted-by":"publisher","first-page":"5783","DOI":"10.1002\/cam4.4124","article-title":"Diverse patient trajectories during cytotoxic chemotherapy: capturing longitudinal patient-reported outcomes","volume":"10","author":"Azad","year":"2021","journal-title":"Cancer Med"},{"key":"2026060406350092000_oyag094-B48","doi-asserted-by":"publisher","first-page":"747","DOI":"10.6004\/jnccn.2019.7385","article-title":"Functional impairment, symptom burden, and clinical outcomes among hospitalized patients with advanced cancer","volume":"18","author":"Lage","year":"2020","journal-title":"J Natl Comp Cancer Netw"},{"key":"2026060406350092000_oyag094-B49","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/jgs.15864","article-title":"Association between symptom burden and physical function in older patients with cancer","volume":"67","author":"Pandya","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"2026060406350092000_oyag094-B50","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/jgs.15493","article-title":"Functional decline and resilience in older women receiving adjuvant chemotherapy for breast cancer","volume":"67","author":"Hurria","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"2026060406350092000_oyag094-B51","doi-asserted-by":"publisher","first-page":"101476","DOI":"10.1016\/j.jgo.2023.101476","article-title":"Functional decline and resilience in older adults over the age of 70 receiving radiotherapy for breast cancer: a pilot study","volume":"14","author":"Akkila","year":"2023","journal-title":"J Geriatr Oncol"},{"key":"2026060406350092000_oyag094-B52","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/gerona\/glv202","article-title":"Physical resilience in older adults: systematic review and development of an emerging construct","volume":"71","author":"Whitson","year":"2016","journal-title":"J Gerontol\u2013Series A Biol Sci Med Sci"},{"key":"2026060406350092000_oyag094-B53","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jgo.2016.07.009","article-title":"Physical resilience of older cancer survivors: an emerging concept","volume":"7","author":"Duan-Porter","year":"2016","journal-title":"J Geriatr Oncol"},{"key":"2026060406350092000_oyag094-B54","doi-asserted-by":"publisher","first-page":"100334","DOI":"10.1016\/j.jtocrr.2022.100334","article-title":"Functional trajectories and resilience among adults with advanced lung cancer","volume":"3","author":"Presley","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"2026060406350092000_oyag094-B55","doi-asserted-by":"publisher","first-page":"107953","DOI":"10.1016\/j.lungcan.2024.107953","article-title":"Functional resilience and overall survival in adults treated for advanced non-small-cell lung cancer","volume":"196","author":"Presley","year":"2024","journal-title":"Lung Cancer"},{"key":"2026060406350092000_oyag094-B56","doi-asserted-by":"publisher","first-page":"101421","DOI":"10.1016\/j.jgo.2022.101421","article-title":"Intrinsic capacity and resilience: taking frailty to the next level","volume":"14","author":"Hamaker","year":"2023","journal-title":"J Geriatr Oncol"},{"key":"2026060406350092000_oyag094-B57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s13670-019-0276-2","article-title":"Frailty, successful aging, resilience, and intrinsic capacity: a cross-disciplinary discourse of the aging process","volume":"8","author":"Woo","year":"2019","journal-title":"Curr Geriatr Rep"},{"key":"2026060406350092000_oyag094-B58","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/jgs.15233","article-title":"Physical resilience: not simply the opposite of frailty","volume":"66","author":"Whitson","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"2026060406350092000_oyag094-B59","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/gerona\/glx015","article-title":"Report: NIA workshop on measures of physiologic resiliencies in human aging","volume":"72","author":"Hadley","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026060406350092000_oyag094-B60","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.jgo.2021.06.007","article-title":"Prevalence of and factors associated with treatment modification at first cycle in older adults with advanced cancer receiving palliative treatment","volume":"12","author":"Mohamed","year":"2021","journal-title":"J Geriatr Oncol"},{"key":"2026060406350092000_oyag094-B61","doi-asserted-by":"publisher","first-page":"e580","DOI":"10.1093\/oncolo\/oyac053","article-title":"Polypharmacy, potentially inappropriate medications, and drug-drug interactions in vulnerable older adults with advanced cancer initiating cancer treatment","volume":"27","author":"Ramsdale","year":"2022","journal-title":"Oncologist"},{"key":"2026060406350092000_oyag094-B62","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1016\/j.jpainsymman.2017.10.024","article-title":"What do \u201cnone,\u201d \u201cmild,\u201d \u201cmoderate,\u201d \u201csevere,\u201d and \u201cvery severe\u201d mean to patients with cancer? Content validity of PRO-CTCAETM response scales","volume":"55","author":"Atkinson","year":"2018","journal-title":"J Pain Symptom Manage"},{"key":"2026060406350092000_oyag094-B63","doi-asserted-by":"publisher","first-page":"365","DOI":"10.22034\/APJCP.2018.19.2.365","article-title":"Symptom severity, anxiety, depression, self- efficacy and quality of life in patients with cancer","volume":"19","author":"Omran","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"2026060406350092000_oyag094-B64","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jpainsymman.2007.03.012","article-title":"Establishing mild, moderate, and severe scores for cancer-related symptoms: how consistent and clinically meaningful are interference-based severity cut-points?","volume":"35","author":"Given","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"2026060406350092000_oyag094-B65","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jpainsymman.2008.01.010","article-title":"Do interference-based cut-points differentiate mild, moderate, and severe levels of 16 cancer-related symptoms over time?","volume":"37","author":"Jeon","year":"2009","journal-title":"J Pain Symptom Manage"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/advance-article-pdf\/doi\/10.1093\/oncolo\/oyag094\/67454266\/oyag094.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/31\/6\/oyag094\/67454266\/oyag094.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/31\/6\/oyag094\/67454266\/oyag094.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:35:08Z","timestamp":1780569308000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/doi\/10.1093\/oncolo\/oyag094\/8532529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,5,8]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyag094","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,3,20]]},"article-number":"oyag094"}}